Sustained hair regrowth with continued ritlecitinib treatment through Week 48 in patients with alopecia areata with or without early target responses: post hoc analysis of the ALLEGRO phase 2b/3 trial

Authors: Mirmirani, Paradi | Journal Of The American Academy Of Dermatology | October 16, 2024 | PubMed abstract

Explore all publications

Back To Top